OSCR — Oscar Health Income Statement
0.000.00%
Last trade - 00:00
- $4.03bn
- $2.46bn
- $5.86bn
- 35
- 46
- 94
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 488 | 463 | 1,839 | 3,964 | 5,863 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 748 | 865 | 2,403 | 4,554 | 6,098 |
Operating Profit | -259 | -402 | -565 | -590 | -236 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -259 | -406 | -571 | -610 | -267 |
Provision for Income Taxes | |||||
Net Income After Taxes | -261 | -407 | -571 | -610 | -271 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -261 | -407 | -573 | -606 | -271 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -261 | -407 | -573 | -606 | -271 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.34 | -2.24 | -3.12 | -2.85 | -1.22 |
Dividends per Share |